Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment

Y Huang, X Guo, Y Wu, X Chen, L Feng, N **e… - … and Targeted Therapy, 2024 - nature.com
Inflammation-associated diseases encompass a range of infectious diseases and non-
infectious inflammatory diseases, which continuously pose one of the most serious threats to …

Vaccines for COVID-19: a systematic review of immunogenicity, current development, and future prospects

Z Zhang, Q Shen, H Chang - Frontiers in immunology, 2022 - frontiersin.org
The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK …

R Lazarus, S Baos, H Cappel-Porter… - The Lancet, 2021 - thelancet.com
Background Concomitant administration of COVID-19 and influenza vaccines could reduce
burden on health-care systems. We aimed to assess the safety of concomitant administration …

Association of influenza vaccination with cardiovascular risk: a meta-analysis

B Behrouzi, DL Bhatt, CP Cannon, O Vardeny… - JAMA network …, 2022 - jamanetwork.com
Importance Influenza infection is associated with increased cardiovascular hospitalization
and mortality. Our prior systematic review and meta-analysis hypothesized that influenza …

[HTML][HTML] Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 …

R Izikson, D Brune, JS Bolduc, P Bourron… - The Lancet …, 2022 - thelancet.com
Background Concomitant seasonal influenza vaccination with a COVID-19 vaccine booster
could help to minimise potential disruption to the seasonal influenza vaccination campaign …

[HTML][HTML] Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian …

L Moscara, V Venerito, A Martinelli, A Di Lorenzo… - Vaccine, 2023 - Elsevier
Abstract In October/December 2021, World Health Organization and other international
agencies recommended the offer of the third dose of anti-SARS-CoV-2 vaccine. In this …

Timing and sequence of vaccination against COVID-19 and influenza (TACTIC): a single-blind, placebo-controlled randomized clinical trial

EA Dulfer, B Geckin, EJM Taks… - The Lancet Regional …, 2023 - thelancet.com
Background Novel mRNA-based vaccines have been used to protect against SARS-CoV-2,
especially in vulnerable populations who also receive an annual influenza vaccination. The …

Immunogenicity and reactogenicity of coadministration of COVID-19 and influenza vaccines

T Gonen, N Barda, K Asraf, G Joseph… - JAMA network …, 2023 - jamanetwork.com
Importance COVID-19 and seasonal influenza vaccines were previously given separately,
although their coadministration is warranted for vaccination adherence. Limited data on their …

[HTML][HTML] Covid-19: virology, variants, and vaccines

M Young, H Crook, J Scott, P Edison - BMJ medicine, 2022 - ncbi.nlm.nih.gov
Abstract As of 25 January 2022, over 349 million individuals have received a confirmed
diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS …

COVID-19 and seasonal influenza vaccination: cross-protection, co-administration, combination vaccines, and hesitancy

A Domnich, A Orsi, CS Trombetta, G Guarona… - Pharmaceuticals, 2022 - mdpi.com
SARS-CoV-2 and influenza are the main respiratory viruses for which effective vaccines are
currently available. Strategies in which COVID-19 and influenza vaccines are administered …